Current issues on Hibinfection in Belarus, Kazakhstan and Russia

Current issues on Hibinfection in Belarus, Kazakhstan and Russia

Show other versions (1)

H. influenzae type B (HIB), is an important cause of serious infections in children, the second frequent in pneumonia and meningitis in children under 5. Every year it leads to an estimated 250–300 thousands of HIB associated meningitis all over the world with 40–50 thousands of lethal outcomes amon...

Full description

Bibliographic Details
Main Author:	A.A. Baranov
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2006-03-01
Series:	Voprosy Sovremennoj Pediatrii
Subjects:	hib infection children morbidity vaccination
Online Access:	https://vsp.spr-journal.ru/jour/article/view/600

Similar Items

Current issues on Hibinfection in Belarus, Kazakhstan and Russia
by: A.A. Baranov
Published: (2006-01-01)

FAMILIAL CASE OF PURULENT HAEMOPHILUS INFLUENZAE MENINGITIS
by: T. V. Egorova, et al.
Published: (2017-09-01)

The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2017-06-01)

Nasopharyngeal colonization by Haemophilus influenzae in children attending day-care centers, in Ribeirão Preto, State of São Paulo, Brazil Colonização da nasofaringe por Haemophilus influenzae em crianças que freqüentam creches em Ribeirão Preto, Estado de São Paulo, Brasil
by: Maria E.N. Bonifácio da Silva, et al.
Published: (2006-03-01)

Progress towards meningitis prevention in the conjugate vaccines era
by: Cristina Aparecida Borges Laval, et al.

Current trends in paediatric infections in the Russian Federation
by: Yu. V. Lobzin, et al.
Published: (2020-08-01)

Long Term Impact of Conjugate Vaccines on <i>Haemophilus influenzae</i> Meningitis: Narrative Review
by: Mary Paulina Elizabeth Slack
Published: (2021-04-01)

Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
by: Reinaldo de Menezes Martins, et al.
Published: (2008-11-01)

Lagging Immune Response to <i>Haemophilus influenzae</i> Serotype b (Hib) Conjugate Vaccine after the Primary Vaccination with Hib of Infants in The Netherlands
by: Leo Schouls, et al.
Published: (2020-06-01)

Rapid assessment of Hib disease burden in Vietnam
by: Slack Mary PE, et al.
Published: (2011-04-01)

THE SAFETY OF HAEMOPHILUS INFLUENZAE TYPE B/POLYRIBOSYLRIBITOL PHOSPHATE-TETANUS (HIB/PRP-T) VACCINE, PHASE I STUDY
by: Kusnandi Rusmil, et al.
Published: (2015-09-01)

Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine
by: A.E.C.C. de Almeida, et al.
Published: (2005-05-01)

Trends and health burden of hospitalized acute respiratory infections and impact of Haemophilus influenza immunization in a Tunisian university hospital: a twelve-year study
by: Manel Ben Fredj, et al.
Published: (2020-01-01)

SAFETY OF PEDIATRIC COMBINATED VACCINE FOR DIPHTHERIA, PERTUSSIS, TETANUS, POLIO AND HAEMOPHILUS INFLUENZA TYPE B IN THE PRIMARY IMMUNIZATION AND FIRST BOOSTERISATION
by: N. D. Chernova, et al.
Published: (2012-08-01)

RESULTS OF A MULTICENTER CLINICAL STUDY OF A NEW COMBINATION VACCINE DTaP-HepB+Hib PRODUCTION OF THE CPA «MICROGEN» FOR IMMUNIZATION OF CHILDREN 6 MONTHS
by: I. V. Feldblyum, et al.
Published: (2018-04-01)

DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
by: Hartono Gunardi, et al.
Published: (2018-05-01)

Vaccination against Haemophilus influenzae type b in the Russian Federation and Abroad
by: N. A. Ozeretskovsky, et al.
Published: (2016-02-01)

Increasing Incidence of Invasive Haemophilus influenzae Disease in Adults, Utah, USA
by: Matthew P. Rubach, et al.
Published: (2011-09-01)

PHARMACOECONOMIC ANALYSIS OF USE OF PENTAVALENT COMBINATION VACCINE WITH ACELLULAR PERTUSSIS COMPONENT IN THE FRAMEWORK OF THE REGIONAL IMMUNIZATION SCHEDULE OF KRASNODAR FOR ALL CHILDREN AGED 0–18 MONTHS AND SEPARATLY FOR CHILDREN AT RISK
by: A. Yu. Kulikov, et al.
Published: (2014-11-01)

The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule
by: Irina V. Mikheeva, et al.
Published: (2019-09-01)

Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study
by: Kusnandi Rusmil, et al.
Published: (2013-12-01)

Conjugate vaccine and carriage of Haemophilus influenzae type b
by: Barbour, Marina Louise
Published: (1993)

Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs
by: Michael L. Jackson, et al.
Published: (2012-01-01)

Economic Evaluation and Budget Impact Analysis of Vaccination against Haemophilus influenzae Type b Infection in Thailand
by: Surachai Kotirum, et al.
Published: (2017-11-01)

RNA gene profile variation in peripheral blood mononuclear cells from rhesus macaques immunized with Hib conjugate vaccine, Hib capsular polysaccharide and TT carrier protein
by: Jing Tang, et al.
Published: (2018-01-01)

Invasive Haemophilus influenzae Disease, Europe, 1996–2006
by: Shamez Ladhani, et al.
Published: (2010-03-01)

Incidência de episódios hipotônicos-hiporresponsivos associados à vacina combinada DTP/Hib usada no Programa Nacional de Imunizações Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program
by: Reinaldo M. Martins, et al.
Published: (2007-12-01)

Epidemiology of Haemophilus influenzae Serotype a, North American Arctic, 2000–2005
by: Michael G. Bruce, et al.
Published: (2008-01-01)

SPREAD AND PRIMARY MANIFESTATIONS OF ROTAVIRUS INFECTION MORBIDITY IN DIFFERENT PARTS OF THE WORLD
by: V. V. Kudryavtsev, et al.
Published: (2013-07-01)

Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
by: David W. McCormick, et al.
Published: (2011-04-01)

Evaluation of Haemophilus influenzaetype b carrier status among children 10 years after the introduction of Hib vaccine in Brazil
by: Rosemeire Cobo Zanella, et al.
Published: (2015-09-01)

<i>Haemophilus</i><i> influenzae</i> type <i>b</i>. Incidence rate and preventive vaccination
by: M. V. Abramtseva, et al.
Published: (2018-02-01)

SAFETY AND IMMUNOGENICITY OF A NATIONAL COMBINED VACCINE AGAINST PERTUSSIS, DIPHTHERIA, TETANUS, HEPATITIS B AND Hib-INFECTION, CONTAINING ACELLULAR PERTUSSIS COMPONENT, DURING IMMUNIZATION OF ADULTS
by: I. V. Feldblyum, et al.
Published: (2016-02-01)

Tendência das meningites por Haemophilus influenzae tipo b no Brasil, em menores de 5 anos, no período de 1983 a 2002 Trends in Haemophilus influenzae type b meningitis in Brazil in children under five years of age from 1983 through 2002
by: Sybelle de Souza Castro Miranzi, et al.
Published: (2006-10-01)

Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
by: D.C.S. Matos, et al.
Published: (2009-12-01)

Genotyping of Haemophilus influenzae type b strains and their incidence in the clinical samples isolated from Iranian patients
by: Somayeh Bagherzadeh-Khodashahri, et al.
Published: (2015-11-01)

Safety of pentavalent DTaP-IPV/Hib combination vaccine in post-marketing surveillance in Guangzhou, China, from 2011 to 2017
by: Zhiqun Li, et al.
Published: (2020-10-01)

The current status of the problem with systemic lupus erythematosus in Kazakhstan
by: B. G. Isayeva, et al.
Published: (2020-03-01)

On the customs union of Belarus, Kazakhstan and Russia
by: Simon György Jr.
Published: (2010-01-01)

Anti-Multiple Myeloma Potential of Secondary Metabolites from <i>Hibiscus sabdariffa</i>
by: Alessio Malacrida, et al.
Published: (2019-07-01)